Noah Fishbein’s Post

View profile for Noah Fishbein, graphic

Director, Sales at MJH Life Sciences™

All-Star line up from our most recent Peer Exchange: Marla Dubinsky, David Rubin, Miguel Regueiro, Remo Panaccione, Sara Horst take the set here to discuss targeting objective treatment goals in Chron's Disease. In our first episode the experts discuss the need to move beyond these initial treatments and consider advanced therapies for moderate to severe cases. The hesitancy to adopt advanced therapies is attributed to factors such as clinician comfort, historical practices, and the predictability of corticosteroid response. The experts highlight he idea to use steroids as a temporary solution while promptly planning for more effective and long-term management strategies. The challenges of short patient visits in community practices are acknowledged, but the importance of initiating discussions about advanced therapy early in the treatment process is underscored. #gastroenterology #ibd

Factors Guiding Treatment Choice in Crohn’s Disease

Factors Guiding Treatment Choice in Crohn’s Disease

hcplive.com

Tim Cope

U.S. Head of Marketing, Respiratory | Commercial Leader | Thought Partner | Results Driven | Mentor

9mo

That’s a power group right there!

To view or add a comment, sign in

Explore topics